Hib-DTP-acellular poliovirus vaccine (Beijing Minhai)
吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗（北京民海）
Report date: 2025/09/30 20:00:06
Base Information
Drug NameHib-DTP-acellular poliovirus vaccine (Beijing Minhai)
Drug Alias Name
Classification +[7]
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications +[11]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A